Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-04

Clinical Trial Update: A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine [Phase 2]

View source ↗

Summary

Phase 2 trial comparing a zidovudine/didanosine/nevirapine combo versus zidovudine/didanosine in HIV infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Didanosine (didanosine)
  • NEVIRAPINE (nevirapine)
  • Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED